Concepedia

Markus Fabits

MF

Statistics

Publications

4

Citations

87

H-Index

4

Active since

2020

Affiliations

Comprehensive Cancer Center Vienna(Current)

Medical University of Vienna

Boehringer Ingelheim (Austria)

Boehringer Ingelheim (Germany)

Markus Fabits is an author at Comprehensive Cancer Center Vienna specializing in immunology, tumor antigens, and tumor-associated antigen targeting.

ORCID

Publications per year

2020–2024

4

Publications

4

The Cytomegalovirus Tegument Protein UL35 Antagonizes Pattern Recognition Receptor-Mediated Type I IFN Transcription

Markus Fabits, Vladimir Gonçalves Magalhães, Baca Chan et al. · Microorganisms · 2020 · 30 citations · Full text

, , +17

Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures

Julijan Kabiljo, A Theophil, J Homola et al. · Journal for ImmunoTherapy of Cancer · 2024 · 22 citations · Full text

, , +17

A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal Tumors

Wei Zhang, Aurélie Auguste, Xiaoyun Liao et al. · Clinical Cancer Research · 2022 · 19 citations · Full text

, , +17

LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager

Leticia Corrales, Susanne Hipp, Katharina D. Martin et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

, , +17

1–4 of 4